Europe Breast Reconstruction Market Forecast to 2028: Inframammary Segment has the Largest Share of Technology During 2021-2028 - ResearchAndMarkets.com

The "Europe Breast Reconstruction Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology, Type; Placement, Procedure" report has been added to ResearchAndMarkets.com's offering.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Monday, September 20, 2021
Information
Tags: 
Surgery, Health, Technology, CQD, Breast, Pancreatic cancer, CAGR, FDA, Cancer, COVID-19, Patient, Death, Hospital, Allergan, Growth, Coronavirus, Prevalence, Awareness, Fear, Johnson & Johnson, Research, Radiation, Anxiety, Breast cancer, Pharmaceutical industry
Geotags: 
Europe, FRANCE, US, SPAIN, ITALY, ROME, UK, GERMANY
⚠generated by AI ↴
Summary
Key Points: 
  • The "Europe Breast Reconstruction Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology, Type; Placement, Procedure" report has been added to ResearchAndMarkets.com's offering.
  • The market for breast reconstruction market is segmented into technology, type, placement, and procedure.
  • Based on technology, the breast reconstruction market is segmented into inframammary, peri-areolar, trans-axillary, and transumbilical.
  • In 2020, the inframammary by technology segment accounted for the largest share of the market.


The "Europe Breast Reconstruction Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology, Type; Placement, Procedure" report has been added to ResearchAndMarkets.com's offering.

The European Breast Reduction market is expected to reach US$ 197.2 million by 2028 from US$ 135.8 million in 2021. The market is estimated to grow at a CAGR of 5.5% from 2021 to 2028.

The growth of this market is estimated to grow owing to key driving factors such as the high prevalence of breast cancer and new product launches and FDA approvals are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the low awareness regarding reimbursement policies.

The impact of the COVID-19 pandemic on cancer patients is high in terms of anxiety, fear, and psychological distress. Among all European countries, Spain, Italy, Germany, France, and UK are most affected due to increasing number of coronavirus cases and deaths associated with it. According to the research led by Codice Viola, charity that supports pancreatic cancer patients found that more than 500 breast or pancreatic patients' appointments for chemotherapy or radiotherapy were postponed. Additionally, 64% of surgical procedures were postponed and more than half have had follow-up appointments rescheduled. The Covid-19 pandemic has challenged hard the national health systems worldwide. According to the national policy issued in March 2020 in response to the evolving Covid-19 pandemic, several hospitals were re-configured as Covid-19 centers and elective surgery procedures were rescheduled according to the most recent recommendations. In addition, Covid-19 protected cancer hubs were established, including the Regina Elena National Cancer Institute of Rome, Central Italy.

The market for breast reconstruction market is segmented into technology, type, placement, and procedure. Based on technology, the breast reconstruction market is segmented into inframammary, peri-areolar, trans-axillary, and transumbilical. In 2020, the inframammary by technology segment accounted for the largest share of the market. Growth of this segment is attributed to rising emphasis on aesthetic appearance and rising number of product launches. However, peri-areolar technology segment is estimated to register the highest CAGR during the forecast period.

Allergan Plc, Mentor Worldwide LLC (Subsidiary of Johnson & Johnson), GC Aesthetics PLC, POLYTECH Health & Aesthetics GmbH, HANSBIOMED CO. LTD, Establishment Labs S.A. and Groupe Sebbin SAS are among the leading companies in the Europe breast reconstruction market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.

Key Topics Covered:

1. Introduction

2. Europe Breast Reconstruction Market - Key Takeaways

3. Research Methodology

4. Europe Breast Reconstruction Market - Market Landscape

5. Europe Breast Reconstruction Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 High Prevalence of Breast Cancer

5.1.2 New Product Launches and FDA Approvals

5.2 Market Restraints

5.2.1 Low Awareness Regarding Reimbursement Policies

5.3 Market Opportunities

5.3.1 Development of Innovative Breast Reconstruction Products

5.4 Future Trends

5.4.1 Adoption of Acellular Dermal Matrices

5.5 Impact Analysis

6. Breast Reconstruction Market - Europe Analysis

7. Europe Breast Reconstruction Market Analysis and Forecasts To 2028 - By Technology

8. Europe Breast Reconstruction Market Analysis and Forecasts To 2028 - By Type

9. Europe Breast Reconstruction Market Analysis and Forecasts To 2028 - By Placement

10. Europe Breast Reconstruction Market Analysis and Forecasts to 2028 - By Procedure

11. Breast Reconstruction Market Revenue and Forecasts to 2028 - Geographical Analysis

12. Impact Of COVID-19 Pandemic on Europe Breast Reconstruction Market

13. Industry Landscape

14. COMPANY PROFILES

  • Allergan Plc
  • Mentor Worldwide LLC ( Subsidiary of Johnson & Johnson)
  • GC Aesthetics PLC
  • POLYTECH Health & Aesthetics GmbH
  • HANSBIOMED CO. LTD
  • Establishment Labs S.A.
  • Groupe Sebbin SAS

     

For more information about this report visit https://www.researchandmarkets.com/r/33cw0m

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Copyright: 
Copyright Business Wire 2021